0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  FREE
Lucile Capuron, PhD; Giuseppe Pagnoni, PhD; Daniel F. Drake, PhD; et al.
Arch Gen Psychiatry. 2012;69(10):1044-1053. doi:10.1001/archgenpsychiatry.2011.2094.
Includes: Supplemental Content

Commentary | 
Donald F. Klein, MD
Arch Gen Psychiatry. 1999;56(4):353-354. doi:10.1001/archpsyc.56.4.353.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Editorial  | 
Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma
Jeremy S. Abramson, MD; Raymond T. Chung, MD
JAMA
Original Investigation  | 
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy:  A Randomized Clinical Trial
He Huang, MD; Xueying Li, MD; Jun Zhu, MD, PhD; et al.
JAMA Internal Medicine
Perspective  | 
False-Positive Test Results in a Patient With Severe Hepatitis:  A Teachable Moment—The Risk of Treating the Numbers
Simina R. Luca, MD; Mandana Kayedi, MD; Brian M. Wong, MD
JAMA Pediatrics
Review  | 
Nonalcoholic Fatty Liver Disease:  A Challenge for Pediatricians
Valerio Nobili, MD; Naim Alkhouri, MD; Anna Alisi, PhD; et al.